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OBJECTIVE: To establish a murine experimental model of bile duct obstruction that would enable controlled
observations of the acute and subacute phases of cholestasis.
METHODOLOGY: Adult male isogenic BALB/c mice underwent a bile duct ligation (22 animals) or a sham operation
(10 animals). Fifteen days after surgery, or immediately after the animal’s death, macroscopic findings were noted and
histological study of the liver, biliary tree, and pancreas was performed (hematoxylin-eosin and Masson trichromic staining).
RESULTS: Beginning 24 hours after surgery, all animals from the bile duct ligation  group presented progressive
generalized malaise. All animals presented jaundice in the parietal and visceral peritoneum, turgid and enlarged liver, and
accentuated dilatation of gallbladder and common bile duct. Microscopic findings included marked dilatation and
proliferation of bile ducts with accentuated collagen deposits, frequent areas of ischemic necrosis, hepatic microabscesses,
and purulent cholangitis. Animals from the sham operation group presented no alterations.
CONCLUSION: We established a murine experimental model of induced cholestasis, which made it possible to study
acute and subacute tissue lesions. Our data suggests that in cholestasis, hepatic functional ischemia plays an important role
in inducing hepatic lesions, and it also suggests that the infectious process is an important factor in morbidity and mortality.
DESCRIPTORS: Cholestasis. Ischemic necrosis. Fibrosis. Experimental pathology. Bile duct.
INTRODUCTION
Cholestasis is an impairment in
bile secretion that occurs in many hu-
man liver diseases1. It can be extra-he-
patic when there is a mechanical ob-
stacle in the extra-hepatic biliary
ducts, or it can be intra-hepatic when
the cholestatic process is due to an in-
tra-hepatic mechanical obstacle or to
metabolic changes in the hepatic cell
without any obstruction2.
Although the pathogenic events
culminating in cholestasis differ in
each disease, hepatocellular injury is
an invariant feature of cholestasis,
leading to liver dysfunction, promot-
ing fibrinogenesis, and ultimately re-
sulting in liver failure. Retention and
accumulation of toxic hydrophobic
bile salts within the hepatocytes is par-
tially responsible for the hepatocellu-
lar injury during cholestasis3-5. Other
mechanisms have also been suggested
to be involved.
The purpose of the present study
was to establish a murine experimen-
tal model for the study of the changes
occurring in acute and subacute
phases of cholestasis and to correlate
them with human cholestatic disease.
A better understanding of the disease
can enable the study of potential drugs
that could delay, or even prevent, de-




Thirty-two adult male isogenic
BALB/c mice weighing 24 to 28 g
were used. The animals were obtained
at DTAEP (Technical Directorate of
Support to the Education and Re-
search) of our institution.
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Animals were housed under con-
tinuous observation in appropriate
cages and allowed free access to a
commercial standard diet (Nuvilabâ)
and water ad libitum.
Animal experiments were per-
formed in accordance with the US Na-
tional Institute of Health – Guidelines
for Care and Use of Laboratory Ani-
mals (publication NIH n° 85-25, re-
vised in 1985).
Surgery Procedure
Mice were anesthetized by intra-
peritoneal administration of 2%
thiazine chlorohydrate (0.02 mL) and
ketamine chlorohydrate 0.5% (0.02
mL). After laparotomy, animals under-
went a sham operation (10 animals,
control group) or a common bile duct
ligation (22 animals, study group): the
common bile duct was isolated, dou-
bly ligated, and resected between the
ligatures.
The animals that died within the
first week after surgery were observed
immediately after death.
The surviving mice were sacrificed
15 days after surgery. In both condi-
tions, macroscopic findings were
noted, and the liver and pancreas were
promptly removed for study.
Liver and pancreatic tissue was
10% formalin-fixed and paraffin-em-
bedded. Four mm slides were
hematoxylin-eosin stained for morpho-
logical evaluation, and in the case of




All animals recovered completely
after surgery.
Twenty four-hours after operation,
the clinical condition of all animals
(100%) of study group worsened, with
weight loss, decreasing activity in
cages, pile bristling, yellowed ears, and
darkened and yellow urine.
From the study group, 18 animals
died an average of 5 days after surgery
(3 to 10 days). The other 4 survived
more than 10 days, being sacrificed on
day 15.
Animals from the control group
showed no alteration after surgery, be-
ing sacrificed on day 15.
Macroscopic findings
Study group (Fig. 1)
Jaundice was observed in parietal
and visceral peritoneum of 100% of
the animals.
The biliary bladder and common
bile duct were dilated, becoming as
wide as or even wider than the intesti-
nal loops.
The liver was turgid and enlarged
in all animals, with multiple pointed
pale areas in 8 of them.
Microscopic findings
Study group:
- The hematoxylin-eosin staining of
liver tissue showed high degree of
dilatation and proliferation of the
bile ducts with fibrotic reaction in
the periphery of the majority of
the portal space areas (Figs. 2A
and 2C). There were numerous
nodular small areas of ischemic
necrosis with fibrosis, randomly
distributed (Fig. 2A). A dense infil-
tration of inflammatory cells was
observed, usually surrounding the
biliary ducts, being comprised
mainly of PMN cells, with the pres-
ence of intra-ductal purulent col-
lection (Fig. 2B) and sometimes the
development of microabscesses
(Fig. 2C). The Masson staining
showed an intense deposit of col-
lagen fibers on the wall of the di-
lated portal and intralobular ducts,
usually accompanied by inflamma-
tory cells (Fig. 2D).
- Hematoxylin-eosin staining of
pancreatic tissue revealed a normal
pattern in all animals (not shown).
- Control group: Histological study
showed no alteration in any ani-
mals (not shown).
Figure 1 - Macroscopic aspects: yellowed peritoneum, significant dilatation of the gallbladder
and the common bile duct, and congested liver with pale areas.
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DISCUSSION
The experimental induction of ex-
tra-hepatic cholestasis and secondary
biliary cirrhosis is not always success-
ful. The recanalization of the hepatic
duct after ligation with or without sec-
tion of biliary tree can occur in up to
50% of animals and can be observed
in the first 5 to 7 days after surgery6.
The recanalization process can occur
through the internalization of the he-
patic duct, from below the ligation site
up to the dilated part of the biliary
tree7. There is proliferation of the bil-
iary epithelium of the hepatic duct be-
low the ligation point that, through
time, connects itself to the dilated
proximal portion of the biliary tree8. In
our experiment, there was no recanali-
zation of the duct. The cholestasis in-
duction endeavor was successful. In all
test animals, the common biliary duct
remained totally obstructed until the
end of the experiment. This mainte-
nance of obstruction was probably due
to the fact that, in our study, the com-
mon bile duct was doubly ligated and
resected between the ligatures. The
obstructive jaundice condition was
demonstrated by the coloration of the
parietal and visceral peritoneum, the
auricle, and urine; the accentuated
dilatation of the common biliary duct
and gallbladder above the obstruction
point (Fig. 1); and by the microscopic
findings (Fig. 2A).
One possible complication of sur-
gery of the biliary tree in mice is the
induction of traumatic pancreatitis. In
these animals, the pancreatic tissue
was organized in a distributed pattern
around terminal choledochus. In our
model, the histological study showed
no pancreatic alteration, probably due
to careful manipulation of viscera dur-
ing surgery.
Animals from the control group
presented no clinical, macroscopic, or
microscopic alteration. This observa-
tion excludes the anaesthetic proce-
dure as well as the surgical trauma as
possible causes of injury.
In our study, the very early mortal-
ity was low, with an average survival
time of 5 days. Survival time was long
enough to allow observation of the
histological alterations occurring in
acute and subacute cholestasis.
Our data strongly suggested that an
infectious event, such as cholangitis
and/or septicemia, was the most fre-
quent cause of death of the animals.
Although we did not perform liver tis-
sue or bile culture, animals developed
highly suspicious signs of infection,
exhibiting a worsening of the clinical
condition including, weight loss, pile
bristling and decreased activity. In ad-
dition, multiple microabscesses were
demonstrated in the histological exam.
The invasive manipulation of pa-
tients with obstructive jaundice can
frequently lead to sepsis or infection-
related complications9-11. Intestinal-
derived endotoxemia is implicated in
the pathophysiology of these events.
An impaired endocytic function of the
mononuclear phagocytic system is
suggested as a mechanism of
endotoxemia in the biliary obstruc-
tion12, 13. In addition, absence or a low
level of bile in the small intestine im-
pairs the emulsification and anti-
endotoxic effects of the biliary salts,
resulting in elevated levels of
endotoxins in the large intestine,
which are absorbed through portal cir-
culation14,15. The exact mechanism of
bacterial translocation is not well es-
tablished, but the internalization of
bacteria by enterocytes seems to be
one of the initial events. It has been
demonstrated in vitro that bile-treated
bacteria are less likely to be internal-
ized by enterocytes and more suscep-
tible to intracellular lysis by the same
cells16, compared to non-treated bacte-
ria. This finding demonstrates the pro-
Figure 2 - A: Dilatation and proliferation of the bile ducts surrounded by increased fibrosis
(arrow). Focus of healed necrosis (head arrow). (H & E, 100X magnification). B: Periductal
fibrosis and intraductal purulent cholangitis. (Masson´s technique, 200X magnification). C:
Microabscesses in portal spaces associated with purulent cholangitis. (H & E, 200X magnification).
D: Severe dilatation of bile ducts surrounded by increased collagen tissue (arrow). Periductal
acute inflammation (head arrow). (Masson´s technique, 100X magnification).
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tector role of the bile in the intestine.
Additionally, Kupffer cells exposed to
endotoxins in portal blood produce
higher amounts of PAF (platelet acti-
vator factor), an important inductor of
hepatocellular lesions.
Biochemical changes that occur in
obstructive jaundice can also impair
immunologic system function. Scott-
Conner, et al.17 isolated a serum factor
with immune suppressive action in
animals with obstructive jaundice.
Febrile patients with obstruction of
the bile duct frequently present septi-
cemia, especially due to Gram-negative
organisms. Patients with a partial ob-
struction of the bile duct or cholangi-
tis have a greater amount of bacteria
in bile, sometime as high as that ex-
isting in the colon. The occurrence or
not of systemic sepsis also depends on
the pressure within the biliary tree, i.e.,
on the degree18 of obstruction.
The morphologic features of
cholestasis frequently include bile pig-
ment accumulation within the hepatic
parenchyma, dilated bile canaliculi,
and rupture of canaliculi, which leads
to bile extravasation that is phagocy-
tosed by Kupffer cells. Kupffer cells
filled with bile can also be seen in
long-term cholestasis. Droplets of bile
pigment also accumulate within
hepatocytes, which can take on a
wispy appearance (feathery or foamy
degeneration)19.
With sustained severe obstruction
disease, bile can accumulate inside bil-
iary ducts, ductules, and even in the
parenchyma, leading to formation of
“bile lakes”. Bile accumulation in
hepatocytes can cause cell degenera-
tion: hepatocellular cytoplasm be-
comes translucent and the cells lose
turgidity. The presence of bile lakes is
considered the hallmark of destruction
of large biliary ducts. On the other
hand, the detection of bile accumula-
tion inside bile ducts can also be seen
in sepsis, in some drug reactions, and
in graft rejection.
Although cholestasis was fully
demonstrated in this experiment, we
observed no bile lakes. This aspect
had already been reported once before,
i.e., that in rodents there is no bile lake
accumulation in cholestasis1. Al-
though this finding has not been fully
elucidated, it is probably due to some
anatomic or metabolic particularity of
rodents.
However, although we could not
identify local accumulation of biliary
salts, we cannot exclude a hepatotoxic
role by these products.
In this study, we observed a high
death rate of hepatocytes. As we have
said, this finding may be due to the
great concentration of biliary salts
above the obstruction20,21 or to a func-
tional ischemia caused by the decrease
of portal flow that may accompany
cholestatic diseases22, 23.
Experimental models have shown
a decrease of the portal blood flow in
biliary extra-hepatic obstruction. Stud-
ies with rats and dogs have shown that
this decrease can be as high as 40% to
50%24-26. The decrease of the portal
flow seems not to be counterbalanced
by a corresponding increase of the ar-
terial hepatic flow. Therefore, a net re-
duction of the total hepatic blood flow
results. Other researchers have shown
that the dilatation of the intra-hepatic
biliary ducts increases the portal pres-
sure level after the sinusoids27. In 1991,
experimental studies showed that por-
tal blood flow is reduced during the
extra-hepatic biliary obstruction and
that portal blood flow increased sig-
nificantly after 3 minutes of drainage
of the biliary tree, confirming the
cause-effect relationship between the
ductal obstruction and the decrease of
portal blood flow.
This decrease in hepatic blood flow
predisposes the organ to a state of an-
oxia or even to a functional ischemic
situation28,26 that may be the trigger
factor for the cellular lesions. This
could initiate an oxidative stress con-
dition that would make hepatocytes
and its organelles more susceptible to
the toxic effects of the biliary salts and
bilirubins that would not ordinarily
injury the hepatic cells. In addition,
other studies have shown that the de-
crease of the portal blood flow that oc-
curs in obstructive jaundice makes the
liver functionally dependent on the ar-
terial hepatic blood29-31. In our experi-
ment, we observed many areas of
ischemic necrosis of hepatic tissue,
suggesting that the reduction in por-
tal blood flow may have played an im-
portant role in causing the death of
hepatocytes.
Obstruction of the biliary tree in-
duces distention of upstream bile
ducts. The bile stasis and back pressure
induce proliferation and reduplication
of ducts, termed bile duct prolifera-
tion. The labyrinthine ducts further
slow the bile flow and favor the for-
mation of concrements, which obstruct
the ductal lumens. Additional factors
that hamper bile flow develop as fol-
lows: portal tract edema with peri-
ductular infiltrates of neutrophils and
bile lake formation containing cellu-
lar debris and bile pigment. Unrelieved
obstruction leads to portal tract fibro-
sis, which initially extends into and
subdivides the parenchyma with rela-
tive preservation of hepatic architec-
ture. Ultimately, an end-stage, bile-
stained, cirrhotic liver develops (bil-
iary cirrhosis)19. In our study, we ob-
served great dilatation and accentu-
ated proliferation of bile ducts with
peri-ductular infiltration of
polymorphonucleocytes and accentu-
ated deposits of collagen surrounding
dilated bile ducts. Our results demon-
strate that the characteristic changes of
fibrosis are already present in the acute
phase of cholestasis.
In conclusion, we were successful
in establishing a murine experimental
model of cholestasis induction, ena-
bling the study of the morphologic al-
terations occurring in the acute and
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subacute phases of cholestasis. Our
data suggests that in cholestasis, he-
patic functional ischemia plays an im-
portant role in inducing hepatic le-
sions, and it also suggests that the in-
fectious process is an important factor
in morbidity and mortality. Additional
studies are in progress that are de-
signed to evaluate the participation of
apoptosis/necrosis in the pathology of
cholestasis, as well as to compare his-
tological alterations produced in this
animal model with those that occur in
humans.
RESUMO
PRADO IB e col. - Colestase em mo-
delo experimental em murinos: le-
sões incluem necrose isquêmica
dos hepatócitos. Rev. Hosp. Clín.
Fac. Med. S. Paulo 58(1):27-32,
2003.
OBJETIVO: Realizar um modelo
experimental de obstrução do ducto
biliar que permita uma observação
controlada das fases aguda e subaguda
da colestase.
MÉTODOS: Submeteram-se ca-
mundongos BALB/c, adultos, machos,
a ligadura do ducto biliar (22 animais)
ou a cirurgia-controle (10 animais).
Quinze dias após a cirurgia, ou imedi-
atamente após a morte do animal, fo-
ram observados os achados macros-
cópicos e realizado o estudo histo-
lógico do fígado, árvore biliar e pân-
creas (haematoxylina-eosina e tricrô-
mico de Masson).
RESULTADOS: Vinte e quatro ho-
ras após cirurgia, todos os animais do
grupo ligadura do ducto biliar apresen-
taram estado progressivo de mal estar.
Todos apresentaram icterícia no peri-
tônio parietal e visceral, fígado au-
mentado e congesto, dilatação acen-
tuada da vesícula biliar e do ducto
biliar comum. Os achados microscópi-
cos incluíram: marcada dilatação e
proliferação dos ductos biliares com
acentuada deposição de colágeno, áre-
as freqüentes de necrose isquêmica de
hepatócitos, microabcessos hepáticos
e colangite purulenta. Animais do gru-
po cirurgia-controle não apresentaram
alterações macro ou microscópicas.
CONCLUSÃO: Este estudo conse-
guiu estabelecer um modelo experi-
mental de indução de colestase, pos-
sibilitando a observação das lesões
teciduais agudas e subagudas. Nossos
resultados apontaram a necrose isquê-
mica dos hepatócitos como um impor-
tante fator contribuinte para o distúr-
bio hepático na colestase, sugerindo
uma participação da isquemia funcio-
nal na lesão do tecido. Esse estudo
também sugere o quadro infeccioso
como causa determinante de morte.
DESCRITORES: Colestase.
Necrose isquêmica. Fibrose. Patolo-
gia experimental. Ducto biliar.
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